Skip to content
Pfizer announced yesterday that results from the Phase 3 clinical trial of its maternal vaccine candidate against the highly contagious Respiratory Syncytial Virus (RSV) […]
Pfizer says clinical trial shows their candidate RSV maternal vaccine protects the baby Read More »
U.S. farm productivity continues to grow, but the pace is slowing due to adverse climate conditions, indicating a need for advances in biotech and
Tech solutions needed to boost farm productivity, USDA economists say Read More »
Scientific and commercial acceptance of the use of psychedelics as treatments for PTSD, anxiety, and other mental disorders has created an exciting new field
Industry, regulators opening their minds to psychedelics as treatments Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
As the weather is getting colder with the winter months approaching, the very scary possibility of a “twindemic” of COVID-19 and influenza we’ve discussed
RSV, COVID, and flu ‘tripledemic’ risk runs high Read More »
According to the National Confectioners Association (NCA), 93% of Americans plan to celebrate the 2022 Halloween season. What’s more, the NCA projects an increase
This Halloween, biotech is making your candy haul more sustainable Read More »
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance
How patient advocates can engage with CMS Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
